Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Toulouse
Age
18–99
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Adult patients who had T1-T3, N0-N2, M0 breast cancer
Patients referred to the Menopause center in the context of their breast cancer who were included in the original study evaluating the bone impact of hormone therapy carried out between 2010 "Bone and cardiovascular impact of adjuvant hormone therapy for cancer non-metastatic breast "
Patient who has given her consent for the study (written or verbal) after clear and fair information
You may not be if
Metastatic breast tumor
Absence of adjuvant hormone therapy for patients whose tumor did not express hormone receptors
Patients who have died since the last assessment
Protected adult patient (guardianship, curatorship, safeguard of justice)
Clareo Health | Impact of Adjuvant Hormone Therapy on Bone and Cardiovascular Risk
